MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

Naidu M. Vegi, Josef Klappacher, Franz Oswald, Medhanie A. Mulaw, Amit Mandoli, Verena N. Thiel, Shiva Bamezai, Kristin Feder, Joost H.A. Martens, Vijay P.S. Rawat, Tamoghna Mandal, Leticia Quintanilla-Martinez, Karsten Spiekermann, Wolfgang Hiddemann, Konstanze Döhner, Hartmut Döhner, Hendrik G. Stunnenberg, Michaela Feuring-Buske, Christian Buske

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

34 Citaten (Scopus)

Samenvatting

Homeobox genes are known to be key factors in leukemogenesis. Although the TALE family homeodomain factor Meis1 has been linked to malignancy, a role for MEIS2 is less clear. Here, we demonstrate that MEIS2 is expressed at high levels in patients with AML1-ETO-positive acute myeloid leukemia and that growth of AML1-ETO-positive leukemia depends on MEIS2 expression. In mice, MEIS2 collaborates with AML1-ETO to induce acute myeloid leukemia. MEIS2 binds strongly to the Runt domain of AML1-ETO, indicating a direct interaction between these transcription factors. High expression of MEIS2 impairs repressive DNA binding of AML1-ETO, inducing increased expression of genes such as the druggable proto-oncogene YES1. Collectively, these data describe a pivotal role for MEIS2 in AML1-ETO-induced leukemia.

Originele taal-2Engels
Pagina's (van-tot)498-507
Aantal pagina's10
TijdschriftCell Reports
Volume16
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - 12 jul. 2016
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML'. Samen vormen ze een unieke vingerafdruk.

Citeer dit